HLS Therapeutics (CVE:HLS) will be announcing its earnings results before the market opens on Wednesday, August 15th. Analysts expect the company to announce earnings of C($0.10) per share for the quarter.
HLS Therapeutics (CVE:HLS) last announced its quarterly earnings results on Wednesday, May 16th. The company reported C($0.22) EPS for the quarter, beating the Zacks’ consensus estimate of C($0.23) by C$0.01. The company had revenue of C$16.64 million during the quarter.
Shares of HLS Therapeutics opened at C$8.50 on Monday, according to Marketbeat. HLS Therapeutics has a 52 week low of C$2.30 and a 52 week high of C$11.89.
HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and distributes pharmaceutical products in North American markets. It is focused on treatment products for the central nervous system and cardiovascular specialties. The company was incorporated in 2014 and is headquartered in Toronto, Canada.
See Also: How Do You Make Money With Penny Stocks?
Receive News & Ratings for HLS Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HLS Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.